AMGEN INC Share-Based Compensation 2007-2026 | AMGN
Beta
What is share-based compensation?
Share-based compensation is the non-cash expense of stock options, restricted stock units, and other equity awards granted to employees.
What is AMGEN INC's current share-based compensation?
AMGEN INC (AMGN) annual share-based compensation for 2025 was $494.0M, a 6.79% decline from 2024. AMGEN INC share-based compensation for the quarter ending March 31, 2026 was $75.0M.
What was AMGEN INC's share-based compensation in 2024?
AMGEN INC annual share-based compensation for 2024 was $530.0M, a 22.97% increase from 2023.
What was AMGEN INC's share-based compensation in 2023?
AMGEN INC annual share-based compensation for 2023 was $431.0M, a 7.48% increase from 2022.
What is AMGEN INC's 5-year share-based compensation CAGR?
AMGEN INC share-based compensation grew at a compound annual growth rate (CAGR) of 8.40% from FY2020 to FY2025, going from $330.0M to $494.0M over 5 years.
Share-Based Compensation History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+8.4%
FY2020
$330.0M
→
FY2025
$494.0M
07080910111213141516171819202122232425
5 years selected
Share-Based Compensation History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $494.0M | -6.8% | 10-K |
| FY2024 | $530.0M | +23.0% | 10-K |
| FY2023 | $431.0M | +7.5% | 10-K |
| FY2022 | $401.0M | +17.6% | 10-K |
| FY2021 | $341.0M | +3.3% | 10-K |
| FY2020 | $330.0M | +7.1% | 10-K |
| FY2019 | $308.0M | -1.0% | 10-K |
| FY2018 | $311.0M | -5.5% | 10-K |
| FY2017 | $329.0M | +5.8% | 10-K |
| FY2016 | $311.0M | -3.4% | 10-K |
| FY2015 | $322.0M | -21.1% | 10-K |
| FY2014 | $408.0M | +1.2% | 10-K |
| FY2013 | $403.0M | +11.3% | 10-K |
| FY2012 | $362.0M | +6.2% | 10-K |
| FY2011 | $341.0M | -3.4% | 10-K |
| FY2010 | $353.0M | +24.3% | 10-K |
| FY2009 | $284.0M | +8.4% | 10-K |
| FY2008 | $262.0M | -0.4% | 10-K |
| FY2007 | $263.0M | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →